SunCoke Jumps 8% Ahead of Thursday's Earnings

SunCoke Energy heads into its Q3 results on October 30 with the stock up 8% on the week, an analyst lifting his target, and options positioning at a two-standard-deviation extreme. That combination makes the next 48 hours the most consequential period for the stock in months.

The clearest catalyst for this week's move came from the Street. StoneX analyst Nathan Martin raised his price target to $12 from $10 on October 28, while keeping his Buy rating. At $10.59, the stock now trades above his old target but still below the new one, leaving roughly 13% implied upside to the revised figure. The rest of the coverage picture is more cautious: B. Riley has held a Neutral for some time, with a $9 target last set in February, which now sits 14% below the current price. The analyst mean target of $9.50 is stale and should be read with that in mind, given the StoneX move has not yet been incorporated into a consensus refresh. The direction of travel today, at least from the only active coverage change this week, is upward.

Options positioning has shifted notably in the same direction. Call-side demand has grown enough to push the put/call ratio to 0.10, well above its 20-day average of 0.08, and more than two standard deviations from that mean. That is the highest PCR z-score of the year for this name, and while a ratio of 0.10 is still skewed heavily toward calls in absolute terms, the relative shift in put demand this week is worth noting ahead of the print. The 52-week range for the PCR runs from 0.05 to 0.97, so the market is far from maximum defensiveness, but the week-end move in protection is a clear signal that some holders are hedging.

Short positioning tells a quieter story. Short interest has declined about 14% over the past month to roughly 4.1% of the free float, down from levels above 4.8% in late September. Borrow costs remain negligible at around 0.5%. Availability is extremely loose, with shares available to borrow running at nearly 4,900% of the current short interest, meaning there is no meaningful squeeze dynamic in the lending market. Shorts who want out face no structural impediment, and new shorts face no borrow constraint. This is a market where conviction drives positioning, not mechanics.

The ownership register adds some context. BlackRock holds just over 10% of shares, though its last 13D/G filing in April showed the stake had been cut from 15.4% to 7.7% at that point, with a subsequent institutional filing showing a higher figure as of September. State Street, Dimensional and American Century each hold between 5% and 7.5%, making the top four holders responsible for roughly 30% of the company. All 13D/G filings are passive; no activist is on the register. Stakes are as-last-disclosed around the 5% threshold, and a holder can fall below that level without a further filing. The most recent insider activity of substance was a cluster of open-market purchases by the CFO and a Senior VP in late February, around $5.50 to $5.80 per share. At $10.59 those buyers are sitting on significant paper gains, though the trades are now eight months old and no subsequent insider activity has been filed.

The only available earnings history shows SunCoke fell less than 1% on the day after its July 2026 print, then recovered to post an 11% gain over the following five days. One data point is not a pattern, but it at least suggests the stock has not historically gapped down hard after results. The EPS surprise factor score ranks in the 90th percentile across the ORTEX universe, meaning SunCoke has a strong track record of beating estimates. Among peers this week, AMR gained 6%, METC added 6.2%, and HCC rose 3.8%, suggesting the broader metallurgical coal and steel complex has also had a constructive week, which removes some of the idiosyncratic risk from reading too much into SunCoke's move alone.

The next thing to watch is Thursday's earnings release and whether the results give StoneX's new $12 target fresh support, or hand the Neutral camp at B. Riley a reason to revisit its $9 figure.